Issues related to FDA approved Psychedelics; Issues related to DEA rescheduling of FDA approved products.
2026 · 3rd Quarter (July 1 - Sep 30)
DEFINIUM THERAPEUTICS
Filed by TIBER CREEK GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Oct 6, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- TIBER CREEK GROUP
- Client
- DEFINIUM THERAPEUTICS
- Filing UUID
- 8ff1e840-34cf-4759-8a0e-51ffba920f91
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to FDA approved Psychedelics; Issues related to DEA rescheduling of FDA approved products.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.